HK1129835A1 - Subcutaneous implants releasing an active principle over an extended period of time - Google Patents

Subcutaneous implants releasing an active principle over an extended period of time

Info

Publication number
HK1129835A1
HK1129835A1 HK09107201.1A HK09107201A HK1129835A1 HK 1129835 A1 HK1129835 A1 HK 1129835A1 HK 09107201 A HK09107201 A HK 09107201A HK 1129835 A1 HK1129835 A1 HK 1129835A1
Authority
HK
Hong Kong
Prior art keywords
time
subcutaneous implants
extended period
active principle
principle over
Prior art date
Application number
HK09107201.1A
Other languages
English (en)
Inventor
Patrice Mauriac
Pierre Marion
Original Assignee
Mediolanum Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mediolanum Pharmaceuticals Ltd filed Critical Mediolanum Pharmaceuticals Ltd
Publication of HK1129835A1 publication Critical patent/HK1129835A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
HK09107201.1A 2006-08-02 2009-08-05 Subcutaneous implants releasing an active principle over an extended period of time HK1129835A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT001545A ITMI20061545A1 (it) 2006-08-02 2006-08-02 Particelle in grado di rilasciare il principio attivo per un periodo prolungato di tempo
PCT/EP2007/057969 WO2008015238A2 (en) 2006-08-02 2007-08-01 Subcutaneous implants releasing an active principle over an extended period of time

Publications (1)

Publication Number Publication Date
HK1129835A1 true HK1129835A1 (en) 2009-12-11

Family

ID=37846057

Family Applications (1)

Application Number Title Priority Date Filing Date
HK09107201.1A HK1129835A1 (en) 2006-08-02 2009-08-05 Subcutaneous implants releasing an active principle over an extended period of time

Country Status (18)

Country Link
US (1) US20100003298A1 (de)
EP (1) EP2054037B1 (de)
JP (1) JP2009545564A (de)
KR (1) KR20090037946A (de)
CN (1) CN101553212A (de)
AT (1) ATE451913T1 (de)
AU (1) AU2007280397A1 (de)
BR (1) BRPI0714515A2 (de)
CA (1) CA2659441A1 (de)
DE (1) DE602007003854D1 (de)
EA (1) EA017292B1 (de)
ES (1) ES2337419T3 (de)
HK (1) HK1129835A1 (de)
IT (1) ITMI20061545A1 (de)
MX (1) MX2009001232A (de)
PL (1) PL2054037T3 (de)
PT (1) PT2054037E (de)
WO (1) WO2008015238A2 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009115525A2 (en) * 2008-03-20 2009-09-24 N.V. Organon Preparation of a pharmaceutical composition for increasing bone mineral density

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1311686C (en) * 1986-06-25 1992-12-22 John Weldon Shell Controlled release bioerodible drug delivery system
US5490962A (en) * 1993-10-18 1996-02-13 Massachusetts Institute Of Technology Preparation of medical devices by solid free-form fabrication methods
US5942253A (en) * 1995-10-12 1999-08-24 Immunex Corporation Prolonged release of GM-CSF
US5817343A (en) * 1996-05-14 1998-10-06 Alkermes, Inc. Method for fabricating polymer-based controlled-release devices
IT1304152B1 (it) * 1998-12-10 2001-03-08 Mediolanum Farmaceutici Srl Composizioni comprendenti un peptide ed acido polilattico-glicolicoatte alla preparazione di impianti sottocutanei aventi un prolungato
ATE367803T1 (de) * 2003-06-26 2007-08-15 Mediolanum Pharmaceuticals Ltd Subcutane implantate mit begrenzter initialer wirkstoff-freisetzung und deren anschliessende lineare veränderliche verlängerte freisetzung
JP2007526322A (ja) * 2004-03-02 2007-09-13 マサチューセッツ インスティテュート オブ テクノロジー ナノセル薬物送達系

Also Published As

Publication number Publication date
WO2008015238A8 (en) 2008-06-05
BRPI0714515A2 (pt) 2013-04-24
PL2054037T3 (pl) 2010-05-31
WO2008015238A2 (en) 2008-02-07
EP2054037B1 (de) 2009-12-16
US20100003298A1 (en) 2010-01-07
WO2008015238A3 (en) 2008-03-20
EA200900247A1 (ru) 2009-06-30
ITMI20061545A1 (it) 2008-02-03
DE602007003854D1 (de) 2010-01-28
EP2054037A2 (de) 2009-05-06
ES2337419T3 (es) 2010-04-23
EA017292B1 (ru) 2012-11-30
ATE451913T1 (de) 2010-01-15
CA2659441A1 (en) 2008-02-07
KR20090037946A (ko) 2009-04-16
AU2007280397A1 (en) 2008-02-07
PT2054037E (pt) 2010-03-24
CN101553212A (zh) 2009-10-07
JP2009545564A (ja) 2009-12-24
MX2009001232A (es) 2009-04-28

Similar Documents

Publication Publication Date Title
WO2006127681A3 (en) Delivery systems for managing release of functional ingredients in an edible composition
EA201290596A1 (ru) Фармацевтический состав, содержащий один или более эфиров фумаровой кислоты в разлагаемой матрице
UA100851C2 (ru) Средство для борьбы с паразитами на животных
NZ622566A (en) Chromobacterium bioactive compositions and metabolites
AR050118A1 (es) Composiciones orales y sistemas de liberacion
CR20110042A (es) Forma cristalina de (2s)-(-)-n-(6-cloro-2,3-dihidro-benzo [1,4]dioxin-2-ilmetil)-sulfamida
IL178390A0 (en) Methods and compositions for the treatment, prevention or management of dysfunctional sleep and dysfunctional sleep associated with disease
TW200621268A (en) Antimicrobial copolymers and uses thereof
WO2007041677A3 (en) Soft tissue implants and drug combination compositions, and use thereof
TW200630128A (en) Active ingredient-containing silicone elastomers
UA90780C2 (ru) Инсектицидная композиция бифентрина и обогащенного циперметрина (варианты) и способы борьбы с насекомыми
ATE551077T1 (de) Minderung einer infektion in zusammenhang mit einer medizinischen vorrichtung
EA200900246A1 (ru) Подкожные имплантаты, высвобождающие активный компонент в течение продолжительного периода времени
IN2012DN00570A (de)
JP2008518699A5 (de)
MX362908B (es) Implantes que contienen fármacos y métodos de uso de los mismos.
AR076139A1 (es) Metodo para el tratamiento de cultivos con un pesticida encapsulado.
TW200635616A (en) Organic compounds
WO2006099232A3 (en) Antimicrobial pet wipes
BRPI0518855A2 (pt) medicamento para aplicaÇço higiÊnica no ouvido
WO2007047426A3 (en) Bioactive delivery matrix compositions and methods
EP1731609A4 (de) Rad51-expressionsinhibitor, den inhibitor als wirkstoff enthaltender arzneistoff und nutzung davon
UY29236A1 (es) 2-alcoxi-3,4,5-trihidroxi-alquilamidas. su preparación, composiciones que las contienen y su utilización.
UA93714C2 (ru) Комбинация активных веществ c инсектицидным действием, применение комбинации kak средства для борьбы c вредителями
MX2009001231A (es) Implantes subcutaneos que liberan un principio activo durante un periodo de tiempo extendido.

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20170801